º»¹®/³»¿ë
½Å°æ¼¼Æ÷¸¦ ÀºÀ¸·Î ¿°»öÇϰí ȯ¿ø½Ã۸é(ȯ¿øÀº¿°»ö reduced silver method) ÇÙÁÖÀ§ºÎ¿Í µ¹±âÀÇ ³»ºÎ¿¡ ÃÖ´ë Á÷°æÀÌ 2 ?m Á¤µµÀÎ ½Å°æ¿ø¼¶À¯(neurofibril)°¡ ³ªÅ¸³´Ù. ±¤ÇÐÇö¹Ì°æ¿¡¼ ³ªÅ¸³ª´Â ÀÌ ½Å°æ¿ø¼¶À¯´Â Á÷°æ 10 nm Á¤µµÀÎ ½Å°æ¹Ì¼¼¼¶À¯(neurofilament)°¡ ¸ð¿© ´Ù¹ßÀ» ÀÌ·ç´Â ±¸Á¶°¡ °üÂûµÇ´Â °ÍÀ̶ó°í ¾Ë·ÁÁ® ÀÖ´Ù. ½Å°æ¹Ì¼¼¼¶À¯´Â Áß°£¹Ì¼¼¼¶À¯(intermediate filament)¿¡ ¼ÓÇϸç, ºÐÀÚ·®ÀÌ 112,000, 102,000, 68,000 Á¤µµÀÎ ´Ü¹éÁú º¹ÇÕüÀÎ ½Å°æ¹Ì¼¼¼¶À¯´Ü¹éÁú(neurofilament protein)·Î ±¸¼ºµÇ¾î ÀÖ´Ù. ÀÌ ½Å°æ¹Ì¼¼¼¶À¯´Ü¹éÁúÀº ½Å°æ¿ø¿¡¸¸ Àֱ⠶§¹®¿¡ ½Å°æ¿ø°ú ´Ù¸¥ ±¸Á¶¸¦ ±¸º°Çϴ ǥÁö¹°Áú(marker substance)ÀÌ µÇ±âµµ ÇÑ´Ù. ¾ËÃ÷ÇÏÀ̸Ӻ´(Altzheimer`s disease)À» ºñ·ÔÇÑ ÀϺΠÅðÇ༺½Å°æÁúȯ(degenerative disease)¿¡¼ ³ªÅ¸³ª´Â ½Å°æ¿ø¼¶À¯µ¢±¼(neurofibrillary tangle)Àº ½Å°æ¹Ì¼¼¼¶À¯´Ü¹éÁúÀÌ º¯¼ºµÇ¾î Çü¼ºµÈ ±¸Á¶·Î ¾Ë·ÁÁ® ÀÖ´Ù.
¼öÃ༺´Ü¹éÁúÀÎ ¾×ƾ(actin)À¸·Î ±¸¼ºµÈ Á÷°æ 3-4 nm ÀÇ ¹Ì¼¼¼¶À¯(microfilaments)´Â ÁÖ·Î ½Å°æ¼¼Æ÷¸·¿¡ ºÎÂøµÇ¾î ÀÖÀ¸¸ç, Æ÷µå¸°(fodrin)À̶ó´Â ´Ü¹éÁúÀÌ ¹Ì¼¼¼¶À¯¸¦ ¼¼Æ÷¸·¿¡ ºÙ¿© ÁØ´Ù. ¼ö»óµ¹±â°¡½Ã(dendritic sp¡¦(»ý·«)
Âü°í¹®Çå
1. ¼Àû
¼Ò¸í¼÷, ÀÎü»ý¸®ÇÐ, °í¹®»ç, 2000
À̼®°, ÀÎü»ý¸®ÇÐ, °èÃ๮Ȼç, 2001
¿À¼ºÃµ, ÀÎü»ý¸®ÇÐ, È¿ÀÏ, 2001
Á¤Èñ°ï, ÀÎü»ý¸®ÇÐ, ±¤¹®°¢, 2002
Á¤¿µ±æ, ÀÎÃ¼ÇØºÎÇÐ, °í¹®»ç, 2002
2.³í¹® ¹× °£Ç๰
õ¿ì¿µ, °ñ°Ý±ÙÀÇ Áö¼ÓÀûÀÎ µîô¼º ¼öÃà½Ã¿¡ ¹ß»ýÇÏ´Â ¼öÃà»óÅ º¯È Æò°¡, ¿ø±¤´ëÇб³, 2000
3.ÀÎÅÍ³Ý »çÀÌÆ®
http://www.nmc.go.kr/library/